FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Somatic Gene Mutation Detection System
PMA: P180043
·
Supplement: S003
·
Decision Nov 16, 2021
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Somatic Gene Mutation Detection System
- Trade Name
- therascreen FGFR RGQ RT-PCR Kit
- PMA Number
- P180043
- Supplement Number
- S003
- Device Class
- FDA Class 3
- Product Code
- OWD
- Generic Name
- Somatic gene mutation detection system
- Medical Specialty
- Unknown
- Advisory Committee
- Medical Genetics
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- November 16, 2021
- Date Received
- September 20, 2021
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for incorporation of a lower boundary for the therascreen FGFR RGQ RT-PCR assay CT cutoff and an update to the software and handbook to address this change.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OWD | Somatic Gene Mutation Detection System | FDA class 3 | Unknown |